Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Derek Jones

Dermatology Los Angeles, CA Medical Doctor

NPI 1245264837 CMS profile 101385

9201 Sunset Blvd #602, Los Angeles, CA 90069

Open in the dashboard

General payments

$271,927

285 records reported · program years 2019–2025

Research payments

$4,862

Paid to them · 12 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$853,838 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Derek Jones of Los Angeles, CA is reported in the CMS Open Payments database as having received $271,927 across 285 general payments and $4,862 in research payments paid to them. Separately, studies naming them as principal investigator received $853,838 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $37,235 40
2024 General $15,229 24
2024 Research $2,079 5
2023 General $33,313 31
2022 General $25,171 47
2022 Research $383 6
2021 General $49,065 51
2021 Research $2,400 1
2020 General $30,891 17
2019 General $81,022 75

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Derek Jones
  • Dermatology median
  • Middle half of Dermatology
  • National median

In program year 2025, general payments to Derek Jones were reported at $37,235. Among 10,363 Dermatology profiles paid that year, the median was $788 and the middle half received between $207 and $1,974.

Show as a table
Year Derek Jones Dermatology median Middle half National median
2019 $81,022 $454 $129–$1,240 $163
2020 $30,891 $235 $81–$756 $114
2021 $49,065 $377 $108–$1,108 $132
2022 $25,171 $514 $143–$1,391 $149
2023 $33,313 $607 $159–$1,674 $160
2024 $15,229 $751 $204–$1,903 $164
2025 $37,235 $788 $207–$1,974 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Allergan Inc. $164,954 110 payments
  2. AbbVie, Inc. $68,195 79 payments
  3. Merz North America, Inc. $26,046 13 payments
  4. Endo Pharmaceuticals Inc. $7,021 11 payments
  5. Galderma Laboratories, L.P. $4,573 19 payments
  6. Novartis Pharmaceuticals Corporation $318 19 payments
  7. Revance Therapeutics, Inc. $216 6 payments
  8. LEO Pharma Inc. $110 5 payments
  9. Sun Pharmaceutical Industries Inc. $84 3 payments
  10. Ortho Dermatologics, a division of Bausch Health US, LLC $63 4 payments
  11. Other $346 16 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $231,758 43 payments
  2. Travel and Lodging $30,893 47 payments
  3. Food and Beverage $4,830 174 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,446 21 payments
Products named General payments · program years 2019–2025
  1. BOTOX COSMETIC $71,848 42 payments
  2. BOTOX $35,252 57 payments
  3. Xeomin $25,965 11 payments
  4. KYBELLA $3,080 1 payment
  5. DAXXIFY $214 5 payments
  6. COSENTYX Immunology $200 16 payments
  7. SKYRIZI $172 8 payments
  8. ENSTILAR $85 4 payments
  9. COSENTYX Dermatology $65 1 payment
  10. ILUMYA $65 2 payments
  11. Other $808 40 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. AbbVie, Inc. $4,862 12 payments

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

18

Median for Dermatology: 534

Drug cost

$176

Median for Dermatology: $67,151

Branded share of claims

0%

Median for Dermatology: 8.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Minoxidil Generic 18 $176

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 13,550 Part D prescribers listed as Dermatology; they describe a distribution and say nothing about conduct.

Payments and prescribing

4 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
BOTOX
  • AbbVie, Inc. $225
$225 — —
DAXXIFY
  • REVANCE THERAPEUTICS, INC. $191
$191 — —
SKYRIZI
  • AbbVie, Inc. $70
$70 — —
Otezla
  • Amgen Inc. $25
$25 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

297 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dermatology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record